International Progressive MS Alliance Announces over €4.6 million in New Funding to Accelerate New Treatments for Progressive MS
December 15, 2023
-- Projects Seek New Insights into Stopping Progression and Improving Well-Being for People with Progressive MS
The International Progressive MS Alliance, a global initiative in which the National MS Society plays a leading role, launched funding for two major initiatives to address the urgent need for new, effective treatments for people living with progressive MS:
- Six new Challenges in Progressive MS Awards will advance the promising findings from projects funded in 2021 to explore mechanisms that drive progression, an area where current lack of knowledge is hindering treatment development.
- The new grants focus on several areas including novel insights into nerve loss, potential pathways for protecting and repairing nervous system tissues, and testing potential drugs to slow progression.
The second new initiative is the Innovations in Well-Being Awards. These are the first phase of a large-scale program to identify and implement solutions to some of the most challenging symptoms that people with progressive MS experience:
- Nine new awards will enable expert teams to develop, test and implement novel therapeutic interventions.
- The new awards focus on the symptoms of pain, mobility, impaired cognition and fatigue. The first phase of the research projects will initiate in early 2024 and report results in mid-2025.
Learn more about both new research awards here
These research investments are only the latest of the ongoing work of the International Progressive MS Alliance. The Alliance is an unprecedented global collaboration of MS organizations, researchers, health professionals, the pharmaceutical industry, companies, trusts, foundations, donors and people affected by progressive MS, working together to address the unmet needs of people with progressive MS ─ rallying the global community to find solutions.
Multiple sclerosis is an unpredictable disease of the central nervous system. Currently there is no cure. Symptoms vary from person to person and may include disabling fatigue, mobility challenges, cognitive changes, and vision issues. An estimated 1 million people live with MS in the United States. Early diagnosis and treatment are critical to minimize disability. Significant progress is being made to achieve a world free of MS.
The National MS Society, founded in 1946, is the global leader of a growing movement dedicated to creating a world free of MS. The Society funds cutting-edge research for a cure, drives change through advocacy and provides programs and services to help people affected by MS live their best lives. Connect to learn more and get involved: nationalMSsociety.org, Facebook, X, formerly known as Twitter, Instagram, YouTube or 1-800-344-4867.